Eczema, atopy and allergen exposure in adults: a population-based study-Reference-Cited by-同舟云学术

Eczema, atopy and allergen exposure in adults: a population-based study

Published:2007-04 Issue:4 Volume:37 Page:526-535
ISSN:0954-7894
Container-title:Clinical & Experimental Allergy
language:en
Short-container-title:Clin Exp Allergy

Author:

Harrop J.,Chinn S.,Verlato G.,Olivieri M.,Norbäck D.,Wjst M.,Janson C.,Zock J.-P.,Leynaert B.,Gislason D.,Ponzio M.,Villani S.,Carosso A.,Svanes C.,Heinrich J.,Jarvis D.

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2222.2007.02679.x/fullpdf

Reference42 articles.

1. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003

2. Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood

3. Clinical aspects, epidemiology, and prognosis of atopic dermatitis

4. Atopic Dermatitis

5. Atopic dermatitis, extrinsic atopic dermatitis and the hygiene hypothesis: results from a cross-sectional study

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Staphylococcus aureus–specific skin resident memory T cells protect against bacteria colonization but exacerbate atopic dermatitis–like flares in mice;Journal of Allergy and Clinical Immunology;2024-08

2. The Impact of Lebrikizumab on Vaccine-Induced Immune Responses: Results from a Phase 3 Study in Adult Patients with Moderate-to-Severe Atopic Dermatitis;Dermatology and Therapy;2024-07-15

3. Stable Response and Sustained Improvement of Itch and Sleep Symptoms in Patients with Atopic Dermatitis Treated with Lebrikizumab over 52 Weeks;Dermatology and Therapy;2024-07-13

4. Lebrikizumab Improves Quality of Life and Patient-Reported Symptoms of Anxiety and Depression in Patients with Moderate-to-Severe Atopic Dermatitis;Dermatology and Therapy;2024-06-26

5. Disease burden, clinical management and unmet treatment need of patients with moderate to severe atopic dermatitis; consensus statements, insights and practices from CERTADE (Central/Eastern EU, Russia, Turkiye AD Experts) Delphi panel;Frontiers in Medicine;2024-06-19